Our pharmaceutical company relentlessly focus to meet current Good Manufacturing Practices (cGMP) standards and regulatory requirements. From clean room operations, to calibration of instruments and preventative maintenance in utilities systems, processes and controls must be effective and strictly enforced. Our finishing and packaging areas ensure high quality manufacturing, but it’s even more than that – it’s a mindset that puts quality above all else
We establish uniform standards for all products, regardless of geography. At Sainor, we believe meeting pharmacopeia requirements is minimum standard. Our policy of continuous process and product improvement drives us to work toward exceeding these minimum standards.
Consistency is rarely an accident. Rather, it is the result of a well-conceived, rigorously implemented Quality Management System (QMS). Our QMS focuses on continual improvement aimed at optimizing processes and eliminating non-value-adding efforts in production. These efforts are primarily directed towards reducing variability in process and product quality characteristics.
Our unwavering commitment to quality goes beyond ourselves. We insist that our business partners comply with national and international regulatory and business standards which are in alignment with those of our own. Our own quality standards are constantly benchmarked against global best practices. This means that these are constantly upgraded to keep pace with the evolving dynamics of the global environment for APIs and intermediates.
To achieve this, we follow a four-step process:
Esomprozole - 501 Kg
Omisulphide -3000 Kg